Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

Would you offer RNI for young patient with cT3N0 triple negative breast cancer that had progression of disease during neoadjuvant chemotherapy, followed by mastectomy and sentinel node biopsy?

2
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · UNC School of Medicine

Yes, without hesitation. The primary randomized data suggesting an improvement in overall survival (OS) with PMRT in the T3N0 setting included RNI (e.g. Overgaard et al., PMID 9395428). There is also a study of +/- PMRT (including regional nodes) in T3 patients (about 40% of which were T3N0), that a...

With the current cisplatin and carboplatin shortages, for HPV+ H&N patients with indications for concurrent chemoRT, which agent do you recommend next?

1
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center

The question of 2nd line therapy is difficult due to the dearth of data. This leaves essentially 3 choices - immunotherapy, cetuximab, or other cytotoxic agents.Regarding immunotherapy, recent trials for concurrent IO have been mixed, tending to compare IO vs Cetux. The main take-home though, is the...

When is it safe for a rectal biopsy in a patient with prior prostate radiation?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Stony Brook University School of Medicine

A biopsy of rectal tissue that has been radiated will have a higher risk of developing non-healing wounds and ulcers. Part of the reason that biopsies are discouraged as well as radiation proctitis is a clinical diagnosis and that biopsies of proctitis are certainly not needed to confirm this. Recta...

How do you proceed with radiation planning for preliminary suspected high grade gliomas after surgery when there is a delay in final molecular diagnosis?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Louisville School of Medicine

While traditionally, for glioblastoma, we start post-operative radiation therapy within 4 weeks of surgery, recent reports (for example, from Israel) have shown better survival if radiation is started at 6 weeks, which should be sufficient time for molecular studies. If for whatever reason radiation...

What is the significance of LVSI in determining post-op management for oropharyngeal cancer?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

It doesn’t change my management.

How do you approach contouring of the ITV for lung SBRT?

2
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Yale School of Medicine

For tumors sitting in the middle of the lung and not near any other moving structures with similar Hounsfield units like mediastinum, larger vessels, chest wall, or diaphragm, then maximum intensity projection is a good place to start (verified with 4D video afterwards). If there is contact with oth...

For esophageal adenocarcinoma with extensive associated Barrett's, would you extend your CTV coverage beyond the usual expansions to cover the areas of known Barrett's?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Brigham and Women's Hospital

The standard GTV to CTV expansions may include much of the Barrett's, but I would not deliberately target the Barrett's disease, whether treating with neoadjuvant or definitive intent. Chemoradiation is not a proven therapy for Barrett's disease, but treating a larger field will expose more heart an...

How would you manage radiation cystitis in a vulvar cancer patient still receiving EBRT with known history of cystocele and who is otherwise hemodynamically stable?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Kentucky

For me, this is a very confusing question. First, I am not sure what is meant by "radiation cystitis." The question seems to imply that the patient is having hematuria as a component of the radiation cystitis diagnosis. In my long career, I have never seen a patient have noticeable hematuria during ...

In patients with perianal squamous cell carcinoma extending to the vulva, would you cover the entire vulva or would generous margins on the gross disease suffice?

1
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · Ohio State University James Cancer Hospital and Solove Research Institute

I would generally favor treating with generous margins as opposed to intentionally covering the entire vulva. However, for patients who have a prior history of vulvar lichen sclerosis or vulvar intraepithelial neoplasia where the risk of developing vulvar cancer is higher, I would consider covering ...

For path CR after neoadjuvant chemotherapy in breast cancer with sentinel node (2-3 nodes) negative but >4 nodes positive on initial PET, do you boost the nodes not assessed by sentinel node?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I have boosted the epicenter of these undissected nodes if can identify on CT sim for planning. For CR or pCR in other nodes usually use 56 to 60 Gy and if non pCR or nodes are still enlarged (like IM or s\c) to 60 to 66 Gy.